Xinze Li
Wenzhou, 325035, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Engineered M2 macrophage-derived vesicles deliver DNase I for cfDNA clearance and multi-organ protection in sepsis.
Journal: International journal of pharmaceutics: X
Published: November 06, 2025
Archaea-inspired deoxyribonuclease I liposomes prevent multiple organ dysfunction in sepsis.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 23, 2024
A strategy for oral delivery of FGF21 for mitigating inflammation and multi-organ damage in sepsis.
Journal: International journal of pharmaceutics
Published: January 18, 2024
Efferocytosis-Inspired Biomimetic Nanoplatform for Targeted Acute Lung Injury Therapy.
Journal: Advanced healthcare materials
Published: December 05, 2023
Kidney targeting peptide-modified biomimetic nanoplatforms for treatment of acute kidney injury.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: January 12, 2023
Self-assembled FGF21 nanoparticles alleviate drug-induced acute liver injury.
Journal: Frontiers in pharmacology
Published: October 31, 2022
Neutrophil membrane-coated therapeutic liposomes for targeted treatment in acute lung injury.
Journal: International journal of pharmaceutics
Published: April 27, 2022
Red Blood Cell Membrane-Camouflaged PLGA Nanoparticles Loaded With Basic Fibroblast Growth Factor for Attenuating Sepsis-Induced Cardiac Injury.
Journal: Frontiers in pharmacology
Published: February 22, 2022
Protective Effects of Chitosan-Bilirubin Nanoparticles Against Ethanol-Induced Gastric Ulcers.
Journal: International journal of nanomedicine
Published: October 17, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026